TPK AGONIST AND METHOD FOR USING SAME TO TREAT NEURODEGENERATIVE DISEASES
Application
US20260076975A1
Kind: A1
Mar 19, 2026
Inventors
Huan ZHANG, Lijuan MENG
Abstract
The present disclosure falls under the field of biomedicine and specifically relates to a method for preventing or treating neurodegenerative diseases or alleviating symptoms of neurodegenerative diseases. An embodiment comprises administering an prophylactically or therapeutically effective dose of a thiamine pyrophosphokinase (TPK) agonist to an individual in need thereof.
CPC Classifications
A61K 31/5513
A61K 31/4045
A61K 31/4184
A61K 31/454
A61K 31/4545
A61K 31/4704
A61K 31/4709
A61K 31/496
A61K 31/498
A61K 31/506
A61K 31/517
A61K 31/519
A61K 31/538
A61K 31/5383
C07D 209/34
C07D 213/74
C07D 215/22
C07D 265/36
C07D 295/13
C07D 295/145
C07D 295/185
C07D 401/04
C07D 401/06
C07D 401/12
C07D 401/14
C07D 403/06
C07D 403/12
C07D 403/14
C07D 405/06
C07D 405/12
C07D 413/12
C07D 417/04
C07D 417/12
C07D 417/14
C07D 471/04
C07D 495/04
C07D 498/04
C07D 513/04
Filing Date
2023-12-01
Application No.
19134735